NCT02063698View on ClinicalTrials.gov

Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 19, 2014

Primary Completion Date

November 11, 2015

Study Completion Date

November 11, 2016

Conditions
Pain
Interventions
DRUG

auranofin

Given PO

OTHER

placebo

Given PO

OTHER

questionnaire administration

Ancillary studies

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER